CD16 Monoclonal Antibody(Q32)

This gene encodes a receptor for the Fc portion of immunoglobulin G, and it is involved in the removal of antigen-antibody complexes from the circulation, as well as other other antibody-dependent responses. This gene (FCGR3A) is highly similar to another nearby gene (FCGR3B) located on chromosome 1. The receptor encoded by this gene is expressed on natural killer (NK) cells as an integral membrane glycoprotein anchored through a transmembrane peptide, whereas FCGR3B is expressed on polymorphonuclear neutrophils (PMN) where the receptor is anchored through a phosphatidylinositol (PI) linkage. Mutations in this gene have been linked to susceptibility to recurrent viral infections, susceptibility to systemic lupus erythematosus, and alloimmune neonatal neutropenia. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.

The CD16 Monoclonal Antibody (Q32) is a highly specialized and meticulously engineered product designed to cater to the needs of the scientific community. This antibody, derived from a hybridoma cell line, exhibits exceptional specificity and affinity towards the CD16 antigen. With its advanced technology and rigorous quality control measures, this antibody ensures reliable and reproducible results in a wide range of applications.

The CD16 Monoclonal Antibody (Q32) is an invaluable tool for researchers and clinicians alike. Its ability to selectively bind to the CD16 antigen, a key marker on natural killer cells and macrophages, enables the precise identification and characterization of these immune cells. This antibody opens up new avenues for studying immune responses, immunotherapy, and disease progression.

The Q32 variant of the CD16 Monoclonal Antibody has been optimized to provide enhanced sensitivity and specificity. Its exceptional binding affinity ensures minimal background noise and maximum signal-to-noise ratio, allowing for accurate and precise detection of the CD16 antigen. This antibody is suitable for various techniques, including flow cytometry, immunohistochemistry, and western blotting.

Our CD16 Monoclonal Antibody (Q32) is manufactured under strict quality control guidelines to ensure batch-to-batch consistency and reliability. Each lot is thoroughly tested for purity, specificity, and functionality, guaranteeing optimal performance and reproducibility. Furthermore, this antibody is produced in compliance with the highest industry standards, ensuring its suitability for use in both research and clinical settings.

In summary, the CD16 Monoclonal Antibody (Q32) is a cutting-edge product that offers unparalleled specificity, sensitivity, and reliability. Its advanced technology and stringent quality control measures make it an indispensable tool for researchers and clinicians in the field of immunology. With its ability to accurately detect and characterize CD16 antigen, this antibody opens up new possibilities for understanding immune responses and developing targeted therapies.